BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 6226339)

  • 1. The basal ganglia in extrapyramidal dysfunction.
    Barnes CD
    Brain Res Bull; 1983 Aug; 11(2):271-5. PubMed ID: 6226339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease.
    Sañudo-Peña MC; Patrick SL; Khen S; Patrick RL; Tsou K; Walker JM
    Neurosci Lett; 1998 Jun; 248(3):171-4. PubMed ID: 9654336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurophysiologic basis of abnormal movements in basal ganglia disorders.
    DeLong MR
    Neurobehav Toxicol Teratol; 1983; 5(6):611-6. PubMed ID: 6422317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physiology and pharmacology of extrapyramidal tract].
    Yoshida M; Mizuno Y
    Nihon Rinsho; 1975 Oct; 33(10):2964-77. PubMed ID: 128646
    [No Abstract]   [Full Text] [Related]  

  • 5. [Movement disorders and basal ganglia function].
    Dietrichs E
    Tidsskr Nor Laegeforen; 2008 Sep; 128(17):1968-71. PubMed ID: 18787574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions.
    Scheel-Krüger J
    Adv Neurol; 1984; 40():85-90. PubMed ID: 6141713
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathophysiology of tardive dyskinesia.
    Gunne LM; Häggström JE
    Psychopharmacology Suppl; 1985; 2():191-3. PubMed ID: 3858799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal ganglia and Parkinson's disease: neurobiological and pharmacological aspects in animals and man.
    Cools AR
    Clin Neurol Neurosurg; 1984; 86(3):178-95. PubMed ID: 6091966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic or secondary basal ganglia diseases and tardive dyskinesias.
    Berardelli A
    Curr Opin Neurol; 1995 Aug; 8(4):320-2. PubMed ID: 7582050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional neuroanatomy of the basal ganglia in Parkinson's disease.
    Wichmann T; DeLong MR
    Adv Neurol; 2003; 91():9-18. PubMed ID: 12442660
    [No Abstract]   [Full Text] [Related]  

  • 11. Static and dynamic state feedback control model of basal ganglia-thalamocortical loops.
    Lörincz A
    Int J Neural Syst; 1997 Jun; 8(3):339-57. PubMed ID: 9427107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia.
    Beyeler A; Kadiri N; Navailles S; Boujema MB; Gonon F; Moine CL; Gross C; De Deurwaerdère P
    Neuroscience; 2010 Aug; 169(1):158-70. PubMed ID: 20447448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current model of basal ganglia organization: a clinician's view.
    Albanese A
    Mov Disord; 1998 Nov; 13(6):980-1. PubMed ID: 9827630
    [No Abstract]   [Full Text] [Related]  

  • 14. The striopallidal system: Its implication in motor disorders.
    Poirier LJ; Parent A; Roberge AG
    Pathobiol Annu; 1975; 5():339-67. PubMed ID: 812038
    [No Abstract]   [Full Text] [Related]  

  • 15. Basal ganglia: functional anatomy and physiology. Part 2.
    Afifi AK
    J Child Neurol; 1994 Oct; 9(4):352-61. PubMed ID: 7822723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease.
    Obeso JA; Rodríguez-Oroz MC; Benitez-Temino B; Blesa FJ; Guridi J; Marin C; Rodriguez M
    Mov Disord; 2008; 23 Suppl 3():S548-59. PubMed ID: 18781672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered.
    Braak H; Del Tredici K
    Exp Neurol; 2008 Jul; 212(1):226-9. PubMed ID: 18501351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease.
    Joel D
    Mov Disord; 2001 May; 16(3):407-23. PubMed ID: 11391734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Somatotopy in the basal ganglia].
    Nanbu A
    Brain Nerve; 2009 Dec; 61(12):1383-94. PubMed ID: 20034305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.
    Bezard E; Gross CE; Brotchie JM
    Trends Neurosci; 2003 Apr; 26(4):215-21. PubMed ID: 12689773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.